| UniProt ID | ATF6A_HUMAN | |
|---|---|---|
| UniProt AC | P18850 | |
| Protein Name | Cyclic AMP-dependent transcription factor ATF-6 alpha | |
| Gene Name | ATF6 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 670 | |
| Subcellular Localization |
Endoplasmic reticulum membrane Single-pass type II membrane protein. Processed cyclic AMP-dependent transcription factor ATF-6 alpha: Nucleus. Under ER stress the cleaved N-terminal cytoplasmic domain translocates into the nucleus. THBS4 promotes i |
|
| Protein Description | Transmembrane glycoprotein of the endoplasmic reticulum that functions as a transcription activator and initiates the unfolded protein response (UPR) during endoplasmic reticulum stress. Cleaved upon ER stress, the N-terminal processed cyclic AMP-dependent transcription factor ATF-6 alpha translocates to the nucleus where it activates transcription of genes involved in the UPR. Binds DNA on the 5'-CCAC[GA]-3'half of the ER stress response element (ERSE) (5'-CCAAT-N(9)-CCAC[GA]-3') and of ERSE II (5'-ATTGG-N-CCACG-3'). Binding to ERSE requires binding of NF-Y to ERSE. Could also be involved in activation of transcription by the serum response factor. May play a role in foveal development and cone function in the retina.. | |
| Protein Sequence | MGEPAGVAGTMESPFSPGLFHRLDEDWDSALFAELGYFTDTDELQLEAANETYENNFDNLDFDLDLMPWESDIWDINNQICTVKDIKAEPQPLSPASSSYSVSSPRSVDSYSSTQHVPEELDLSSSSQMSPLSLYGENSNSLSSAEPLKEDKPVTGPRNKTENGLTPKKKIQVNSKPSIQPKPLLLPAAPKTQTNSSVPAKTIIIQTVPTLMPLAKQQPIISLQPAPTKGQTVLLSQPTVVQLQAPGVLPSAQPVLAVAGGVTQLPNHVVNVVPAPSANSPVNGKLSVTKPVLQSTMRNVGSDIAVLRRQQRMIKNRESACQSRKKKKEYMLGLEARLKAALSENEQLKKENGTLKRQLDEVVSENQRLKVPSPKRRVVCVMIVLAFIILNYGPMSMLEQDSRRMNPSVSPANQRRHLLGFSAKEAQDTSDGIIQKNSYRYDHSVSNDKALMVLTEEPLLYIPPPPCQPLINTTESLRLNHELRGWVHRHEVERTKSRRMTNNQQKTRILQGALEQGSNSQLMAVQYTETTSSISRNSGSELQVYYASPRSYQDFFEAIRRRGDTFYVVSFRRDHLLLPATTHNKTTRPKMSIVLPAININENVINGQDYEVMMQIDCQVMDTRILHIKSSSVPPYLRDQQRNQTNTFFGSPPAATEATHVVSTIPESLQ | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 10 | Phosphorylation | EPAGVAGTMESPFSP CCCCCCCCCCCCCCC | 14.18 | 29759185 | |
| 13 | Phosphorylation | GVAGTMESPFSPGLF CCCCCCCCCCCCCHH | 22.03 | 25850435 | |
| 16 | Phosphorylation | GTMESPFSPGLFHRL CCCCCCCCCCHHHCC | 22.80 | 25850435 | |
| 87 | Sumoylation | ICTVKDIKAEPQPLS EEEHHHCCCCCCCCC | 57.75 | - | |
| 87 | Acetylation | ICTVKDIKAEPQPLS EEEHHHCCCCCCCCC | 57.75 | 26051181 | |
| 87 | Sumoylation | ICTVKDIKAEPQPLS EEEHHHCCCCCCCCC | 57.75 | 28112733 | |
| 87 | Ubiquitination | ICTVKDIKAEPQPLS EEEHHHCCCCCCCCC | 57.75 | 21906983 | |
| 94 | Phosphorylation | KAEPQPLSPASSSYS CCCCCCCCCCCCCCC | 25.71 | 28355574 | |
| 97 | Phosphorylation | PQPLSPASSSYSVSS CCCCCCCCCCCCCCC | 24.17 | 27732954 | |
| 97 | O-linked_Glycosylation | PQPLSPASSSYSVSS CCCCCCCCCCCCCCC | 24.17 | 30379171 | |
| 98 | Phosphorylation | QPLSPASSSYSVSSP CCCCCCCCCCCCCCC | 35.09 | 27732954 | |
| 99 | Phosphorylation | PLSPASSSYSVSSPR CCCCCCCCCCCCCCC | 20.94 | 27732954 | |
| 100 | Phosphorylation | LSPASSSYSVSSPRS CCCCCCCCCCCCCCC | 18.29 | 23312004 | |
| 101 | Phosphorylation | SPASSSYSVSSPRSV CCCCCCCCCCCCCCC | 19.92 | 27732954 | |
| 103 | Phosphorylation | ASSSYSVSSPRSVDS CCCCCCCCCCCCCCC | 28.78 | 25159151 | |
| 104 | Phosphorylation | SSSYSVSSPRSVDSY CCCCCCCCCCCCCCC | 23.37 | 28985074 | |
| 152 | Sumoylation | AEPLKEDKPVTGPRN CCCCCCCCCCCCCCC | 42.34 | - | |
| 152 | Sumoylation | AEPLKEDKPVTGPRN CCCCCCCCCCCCCCC | 42.34 | - | |
| 161 | Phosphorylation | VTGPRNKTENGLTPK CCCCCCCCCCCCCCC | 37.93 | 22210691 | |
| 166 | Phosphorylation | NKTENGLTPKKKIQV CCCCCCCCCCCCEEC | 34.17 | 25002506 | |
| 175 | Phosphorylation | KKKIQVNSKPSIQPK CCCEECCCCCCCCCC | 47.27 | 23532336 | |
| 176 | Ubiquitination | KKIQVNSKPSIQPKP CCEECCCCCCCCCCC | 37.27 | - | |
| 176 | Sumoylation | KKIQVNSKPSIQPKP CCEECCCCCCCCCCC | 37.27 | - | |
| 176 | Acetylation | KKIQVNSKPSIQPKP CCEECCCCCCCCCCC | 37.27 | 23954790 | |
| 176 | Sumoylation | KKIQVNSKPSIQPKP CCEECCCCCCCCCCC | 37.27 | - | |
| 182 | Sumoylation | SKPSIQPKPLLLPAA CCCCCCCCCCEECCC | 31.74 | - | |
| 182 | Acetylation | SKPSIQPKPLLLPAA CCCCCCCCCCEECCC | 31.74 | 26051181 | |
| 182 | Sumoylation | SKPSIQPKPLLLPAA CCCCCCCCCCEECCC | 31.74 | - | |
| 191 | Sumoylation | LLLPAAPKTQTNSSV CEECCCCCCCCCCCC | 48.84 | - | |
| 191 | Sumoylation | LLLPAAPKTQTNSSV CEECCCCCCCCCCCC | 48.84 | - | |
| 201 | Ubiquitination | TNSSVPAKTIIIQTV CCCCCCCEEEEEEEC | 33.90 | 21906983 | |
| 201 | Acetylation | TNSSVPAKTIIIQTV CCCCCCCEEEEEEEC | 33.90 | 26051181 | |
| 216 | Ubiquitination | PTLMPLAKQQPIISL CCCHHHHHCCCEEEE | 58.09 | - | |
| 290 | Sumoylation | NGKLSVTKPVLQSTM CCEECCCHHHHHHHH | 30.85 | - | |
| 290 | Sumoylation | NGKLSVTKPVLQSTM CCEECCCHHHHHHHH | 30.85 | - | |
| 290 | Ubiquitination | NGKLSVTKPVLQSTM CCEECCCHHHHHHHH | 30.85 | - | |
| 296 | Phosphorylation | TKPVLQSTMRNVGSD CHHHHHHHHHHHCHH | 13.74 | - | |
| 302 | Phosphorylation | STMRNVGSDIAVLRR HHHHHHCHHHHHHHH | 22.89 | 26471730 | |
| 330 | Phosphorylation | SRKKKKEYMLGLEAR HHHHHHHHHHHHHHH | 13.40 | 22817900 | |
| 339 | Ubiquitination | LGLEARLKAALSENE HHHHHHHHHHHHHCH | 26.51 | - | |
| 349 | Ubiquitination | LSENEQLKKENGTLK HHHCHHHHHHCCCHH | 58.71 | - | |
| 373 | Phosphorylation | NQRLKVPSPKRRVVC CCCCCCCCHHHHHHH | 46.14 | 23898821 | |
| 410 | Phosphorylation | RRMNPSVSPANQRRH HHCCCCCCHHHHHHH | 23.72 | 26091039 | |
| 424 | Ubiquitination | HLLGFSAKEAQDTSD HHHCCCHHCCCCCCC | 53.00 | 21906983 | |
| 436 | Ubiquitination | TSDGIIQKNSYRYDH CCCCEEECCCEECCC | 37.14 | 21906983 | |
| 472 | N-linked_Glycosylation | PPCQPLINTTESLRL CCCCCCCCCHHHHHC | 48.94 | 14699159 | |
| 474 | O-linked_Glycosylation | CQPLINTTESLRLNH CCCCCCCHHHHHCCH | 21.06 | 14699159 | |
| 474 | O-linked_Glycosylation | CQPLINTTESLRLNH CCCCCCCHHHHHCCH | 21.06 | - | |
| 506 | Ubiquitination | RMTNNQQKTRILQGA CCCCHHHHHHHHHHH | 29.97 | - | |
| 565 | Phosphorylation | AIRRRGDTFYVVSFR HHHHCCCEEEEEEEC | 21.49 | 30622161 | |
| 567 | Phosphorylation | RRRGDTFYVVSFRRD HHCCCEEEEEEECCC | 11.31 | 30622161 | |
| 584 | N-linked_Glycosylation | LLPATTHNKTTRPKM ECEECCCCCCCCCCE | 41.08 | 14699159 | |
| 586 | O-linked_Glycosylation | PATTHNKTTRPKMSI EECCCCCCCCCCEEE | 33.10 | - | |
| 586 | O-linked_Glycosylation | PATTHNKTTRPKMSI EECCCCCCCCCCEEE | 33.10 | 14699159 | |
| 590 | Ubiquitination | HNKTTRPKMSIVLPA CCCCCCCCEEEEEEE | 41.82 | - | |
| 629 | Ubiquitination | DTRILHIKSSSVPPY CCEEEEEECCCCCCC | 33.27 | - | |
| 632 | Phosphorylation | ILHIKSSSVPPYLRD EEEEECCCCCCCCCH | 45.81 | 21659604 | |
| 643 | N-linked_Glycosylation | YLRDQQRNQTNTFFG CCCHHHCCCCCCCCC | 49.00 | 14699159 | |
| 645 | O-linked_Glycosylation | RDQQRNQTNTFFGSP CHHHCCCCCCCCCCC | 39.51 | - | |
| 645 | O-linked_Glycosylation | RDQQRNQTNTFFGSP CHHHCCCCCCCCCCC | 39.51 | 14699159 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 166 | T | Phosphorylation | Kinase | MAPK14 | Q16539 | GPS |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ATF6A_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ATF6A_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| TYY1_HUMAN | YY1 | physical | 10866666 | |
| ATF6A_HUMAN | ATF6 | physical | 11158310 | |
| ATF6B_HUMAN | ATF6B | physical | 11158310 | |
| SRF_HUMAN | SRF | physical | 9271374 | |
| TYY1_HUMAN | YY1 | physical | 15899857 | |
| SRBP2_HUMAN | SREBF2 | physical | 14765107 | |
| SP1_HUMAN | SP1 | genetic | 22354938 | |
| A4_HUMAN | APP | physical | 21832049 | |
| ATF6A_HUMAN | ATF6 | physical | 23661758 | |
| XBP1_HUMAN | XBP1 | physical | 23661758 | |
| PMGE_HUMAN | BPGM | physical | 21988832 | |
| DDC_HUMAN | DDC | physical | 21988832 | |
| NNMT_HUMAN | NNMT | physical | 21988832 | |
| TNR1A_HUMAN | TNFRSF1A | physical | 21988832 | |
| APOD_HUMAN | APOD | physical | 25609649 | |
| S3TC1_HUMAN | SH3TC1 | physical | 25609649 | |
| RFWD2_HUMAN | RFWD2 | physical | 25609649 | |
| STK40_HUMAN | STK40 | physical | 25609649 | |
| ACLY_HUMAN | ACLY | physical | 25609649 | |
| PARG_HUMAN | PARG | physical | 25609649 |
| Kegg Disease | |
|---|---|
| There are no disease associations of PTM sites. | |
| OMIM Disease | |
| There are no disease associations of PTM sites. | |
| Kegg Drug | |
| There are no disease associations of PTM sites. | |
| DrugBank | |
| DB00852 | Pseudoephedrine |
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Underglycosylation of ATF6 as a novel sensing mechanism foractivation of the unfolded protein response."; Hong M., Luo S., Baumeister P., Huang J.M., Gogia R.K., Li M.,Lee A.S.; J. Biol. Chem. 279:11354-11363(2004). Cited for: GLYCOSYLATION AT ASN-472; ASN-584 AND ASN-643, AND MUTAGENESIS OFTHR-474; THR-586 AND THR-645. | |